Incyte Corp (INCY)
70.14
-0.91
(-1.28%)
USD |
NASDAQ |
Nov 21, 14:27
Incyte Price: 70.14 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 70.66 | 71.68 | 70.25 | 71.05 | 2.142M |
| Nov 19, 2024 | 67.11 | 74.10 | 65.02 | 70.56 | 10.88M |
| Nov 18, 2024 | 75.89 | 77.01 | 75.42 | 76.97 | 1.844M |
| Nov 15, 2024 | 77.15 | 77.87 | 73.25 | 75.87 | 3.843M |
| Nov 14, 2024 | 80.16 | 80.46 | 77.58 | 77.73 | 1.876M |
| Nov 13, 2024 | 80.80 | 81.70 | 80.37 | 80.48 | 1.573M |
| Nov 12, 2024 | 81.55 | 82.02 | 80.20 | 80.58 | 1.843M |
| Nov 11, 2024 | 83.54 | 83.54 | 81.16 | 81.53 | 1.881M |
| Nov 08, 2024 | 82.59 | 83.95 | 82.14 | 83.38 | 3.236M |
| Nov 07, 2024 | 81.00 | 82.97 | 79.53 | 82.34 | 2.637M |
| Nov 06, 2024 | 78.45 | 82.19 | 78.21 | 80.95 | 5.292M |
| Nov 05, 2024 | 75.77 | 77.37 | 75.34 | 77.28 | 1.252M |
| Nov 04, 2024 | 75.07 | 76.57 | 75.07 | 75.75 | 1.464M |
| Nov 01, 2024 | 74.12 | 76.33 | 73.91 | 76.13 | 2.262M |
| Oct 31, 2024 | 73.91 | 74.68 | 73.28 | 74.12 | 2.024M |
| Oct 30, 2024 | 73.60 | 74.60 | 72.50 | 73.93 | 2.459M |
| Oct 29, 2024 | 67.53 | 74.07 | 66.95 | 73.60 | 4.572M |
| Oct 28, 2024 | 65.49 | 65.88 | 64.86 | 65.69 | 2.067M |
| Oct 25, 2024 | 65.32 | 65.74 | 64.99 | 65.07 | 1.086M |
| Oct 24, 2024 | 65.24 | 65.91 | 65.08 | 65.24 | 1.209M |
| Oct 23, 2024 | 65.49 | 66.10 | 64.76 | 65.17 | 1.252M |
| Oct 22, 2024 | 65.03 | 65.78 | 64.60 | 65.59 | 735418.0 |
| Oct 21, 2024 | 66.33 | 66.55 | 64.87 | 65.27 | 841024.0 |
| Oct 18, 2024 | 66.41 | 66.95 | 65.90 | 66.39 | 742383.0 |
| Oct 17, 2024 | 65.99 | 66.49 | 65.44 | 66.43 | 1.356M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
51.18
Minimum
Apr 25 2024
109.69
Maximum
Jul 20 2020
74.58
Average
74.31
Median
Mar 10 2020
Price Benchmarks
| Pfizer Inc | 25.01 |
| Biomarin Pharmaceutical Inc | 63.22 |
| Syndax Pharmaceuticals Inc | 15.80 |
| Allogene Therapeutics Inc | 2.10 |
| Arcutis Biotherapeutics Inc | 10.44 |
Price Related Metrics
| PE Ratio | 501.00 |
| PS Ratio | 3.733 |
| Price to Book Value | 4.261 |
| Price to Free Cash Flow | 905.53 |
| Earnings Yield | 0.20% |
| Market Cap | 13.51B |
| Operating PE Ratio | 2504.89 |